L2-FK866
L2-FK866 is an ADC payload-linker conjugate (Drug-linker conjugate for ADC). L2-FK866 contains the ADC linker (Val-Cit-p-aminobenzyl) and the NAMPT inhibitor FK866 (HY-50876). L2-FK866 can be conjugated with Dinutuximab (HY-P9933) to form an ADC. L2-FK866 is applicable to neuroblastoma research.
For research use only. We do not sell to patients.
- Formula: C64H89N15O16S2
- Molecular Weight:1388.61
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Drug-Linker Conjugates for ADC Isoforms
More
Biological Activity
Chemical Information
-
Molecular Weight 1388.61
-
Formula C64H89N15O16S2
-
SMILES
O=C(C1=CC(NC(OCC2=CC=C(NC([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC(CCOCCOCCOCCN3N=NC(CNC([C@H]4N(S(=O)(C=C)=O)CCN(S(=O)(C=C)=O)C4)=O)=C3)=O)=O)=O)C=C2)=O)=CC=C1)N5CCC(CCCCNC(/C=C/C6=CC=CN=C6)=O)CC5
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)